Book Online or Call 1-855-SAUSALITO
Sign In \| Register \| About Sausalito \| Contact Us
Sausalito, CA September 01, 2020 1:41pm 7-Day Forecast \| Traffic

- Apartments

Search Hotels in Sausalito
CHECK-IN:
CHECK-OUT:
ROOMS:

Find A Business
or Browse Listings

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,043.29 -6.31 (-0.60%)

Official Closing Price Updated: 7:00 PM EST, Nov 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

99 100 Next >

Ozempic, Mounjaro Users Cut $6.5 Billion From Grocery Bills: GLP-1 Boom Triggers Panic In Packaged Food Aisles ↗

July 17, 2025

GLP-1 medications are delivering a $6.5 billion blow to U.S. grocery spending, with weight-loss drugs altering consumer purchasing patterns.

Via Benzinga

1 Volatile Stock with Exciting Potential and 2 to Question

July 17, 2025

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced...

Via StockStory

What's going on in today's session: S&P500 movers ↗

July 16, 2025

Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

WeightWatchers (WW) Stock Trades Up, Here Is Why

July 16, 2025

Shares of personal wellness company WeightWatchers (NASDAQ:WW) jumped 4.1% in the morning session after the company successfully completed its strategic reorganization process and announced new program...

Via StockStory

Topics Bankruptcy Initial Public Offering

How Do Investors Really Feel About Eli Lilly? ↗

July 15, 2025

Via Benzinga

This Is What Whales Are Betting On Eli Lilly ↗

July 10, 2025

Via Benzinga

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today ↗

July 16, 2025

Via Benzinga

Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' ↗

July 16, 2025

Barclays has said that it's hard to predict which firm would be affected the most by pharma tariffs, except for Novo Nordisk.

Via Benzinga

Topics Government World Trade

PolyPid’s Game-Changing 60-Day GLP-1 Platform Could Disrupt $100B Weight Loss Market

July 15, 2025

Via AB Newswire

Palatin’s Oral Obesity Drug Shows Remarkable Results: The Hidden Gem in the Weight Loss Race

July 15, 2025

Via AB Newswire

Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook ↗

July 15, 2025

Goldman Sachs raised its year-end S&P 500 forecast and identified three stocks that are poised to outperform in the second half of 2025: KSS, NTLA, and GOGO.

Via MarketBeat

Topics Economy Stocks

10 Health Care Stocks Whale Activity In Today's Session ↗

July 15, 2025

Via Benzinga

1 S&P 500 Stock for Long-Term Investors and 2 to Ignore

July 15, 2025

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Via StockStory

Topics Stocks

Pfizer Faces $1 Billion IRA Reform Hit As Analysts Expect Flat 2025 Outlook ↗

July 14, 2025

Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.

Via Benzinga

Topics Intellectual Property

How To Trade This 150% Gainer Chasing A Cure For Type 1 Diabetes ↗

July 14, 2025

An update on Sana Biotechnology.

Via Benzinga

This Is 'One Of The Hottest Stocks In The Universe,' Jim Cramer Says ↗

July 14, 2025

Rocket Lab notched its fastest launch turnaround ever, completing its 68th Electron mission and signaling a new era of rocket deployment.

Via Benzinga

3 Dividend Growth Stocks to Buy and Hold ↗

July 12, 2025

Via The Motley Fool

Topics Intellectual Property

Market Whales and Their Recent Bets on LLY Options ↗

July 11, 2025

Via Benzinga

A Glimpse Into The Expert Outlook On Eli Lilly Through 7 Analysts ↗

July 11, 2025

Via Benzinga

Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies ↗

July 11, 2025

Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" except for the rest.

Via Benzinga

Topics Government World Trade

Eli Lilly And Company Stock: U.S. FDA Approves Safer Kisunla Dosing For Early Alzheimer’s ↗

July 10, 2025

Eli Lilly stock has risen over 400% in 5 years despite a recent pullback.

Via Talk Markets

Are Growth Stocks Back? 3 That Look Like Winners to Buy Now ↗

July 10, 2025

Three companies are outpacing the market by leading secular trends in medicine, artificial intelligence, and consumer brands, creating durable growth stories.

Via MarketBeat

Topics Artificial Intelligence

3 Profitable Stocks Facing Headwinds

July 10, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

3 Reasons I Bought Novo Nordisk Stock Instead of Eli Lilly ↗

July 09, 2025

Via The Motley Fool

Zepbound Powers Eli Lilly's Upbeat Q2 Outlook ↗

July 09, 2025

BofA slightly raised Q2 estimates for Eli Lilly ahead of earnings as Zepbound sales improve; long-term forecasts for key drugs remain steady.

Via Benzinga

Elon Musk-Led SpaceX Starlink Gets Final Regulatory Approval For Launch In India: Report ↗

July 09, 2025

Reuters reported on Wednesday, citing three sources, that Starlink has cleared the only remaining regulatory hurdle for the satellite provider to enter the market.

Via Stocktwits

FDA Approves New Dosing Schedule For Eli Lilly's Kisunla In Alzheimer's Treatment ↗

July 09, 2025

Lilly's Kisunla gets FDA approval for a new dosing schedule that significantly lowers ARIA-E risk while maintaining amyloid plaque reduction.

Via Benzinga

Eli Lilly’s Alzheimer’s Drug Gets US FDA Label Update For More Gradual Dosing After Study Shows Reduced Side Effects ↗

July 09, 2025

The U.S. FDA approved Kisunla, an amyloid-targeting therapy, in July 2024 after a study showed that it significantly slowed cognitive and functional decline in Alzheimer’s patients who were less...

Via Stocktwits

Trump Threatens 200% Tariffs On Drug Imports, Says Big Pharma Will Get Some Time 'To Get Their Act Together' ↗

July 08, 2025

Pharmaceutical investors are being cautious, with concerns over potential supply disruptions, cost pressures, and uncertainty regarding policy implementation.

Via Stocktwits

Topics ETFs Economy Government

Don’t Miss Out: 3 Blue-Chips Set to Pop This Earnings Season ↗

July 08, 2025

These 3 blue-chip stocks offer strong earnings power and growth opportunities as uncertainty lingers in the second half of 2025

Via MarketBeat

Topics Economy World Trade

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Search Hotels in Sausalito

Find A Business

or Browse Listings

Eli Lilly (NY:LLY)

All News about Eli Lilly